Erratum to "The possible involvement of endogenous ligands for mu-, delta- and kappa-opioid receptors in modulating morphine-induced CPP expression in rats" [Peptides 27 (12) (2006) 3307-3314] (DOI:10.1016/j.peptides.2006.08.011);The possible involvement of endogenous ligands for mu-, delta- and kappa-opioid receptors in modulating morphine-induced CPP expression in rats

Peptides

Volumn 27, Issue 12, 2006, Pages 3307-3314

  Liang, Jing ^a   Li, Yijing ^a   Ping, Xingjie ^a   Yu, Peng ^a   Zuo, Yanfang ^a   Wu, Liuzhen ^a   Han, Ji Sheng ^a,b   Cui, Cailian ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b MCLEAN HOSPITAL   (United States)

Author keywords

Conditioned place preference (CPP); Morphine; Nucleus accumbens (NAc); Opioid receptors

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RAT STRAIN;

EID: 33751080392     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.12.001     Document Type: Erratum

References (48)

1. Akil H., Watson S.J., Young E., Lewis M.E., Khachaturian H., and Walker J.M. Endogenous opioids: biology and function. Annu Rev Neurosci 7 (1984) 223-255
2. Bals-Kubik R., Ableitner A., Herz A., and Shippenberg T.S. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264 (1993) 489-495
3. Bals-Kubik R., Shippenberg T.S., and Herz A. Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat. Eur J Pharmacol 175 (1990) 63-69
4. Chen J.H., Liang J., Wang G.B., Han J.S., and Cui C.L. Repeated 2 Hz peripheral electrical stimulations suppress morphine-induced CPP and improve spatial memory ability in rats. Exp Neurol 194 (2005) 550-556
5. Cotton R., Kosterlitz H.W., Paterson S.J., Rance M.J., and Traynor J.R. The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the delta-binding site. Br J Pharmacol 84 (1985) 927-932
6. Georges F., Stinus L., Bloch B., and Le M.C. Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur J Neurosci 11 (1999) 481-490
7. Glick S.D., Maisonneuve I.M., Raucci J., and Archer S. Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res 681 (1995) 147-152
8. Glimcher P.W., Giovino A.A., Margolin D.H., and Hoebel B.G. Endogenous opiate reward induced by an enkephalinase inhibitor, thiorphan, injected into the ventral midbrain. Behav Neurosci 98 (1984) 262-268
9. Goeders N.E., Lane J.D., and Smith J.E. Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol Biochem Behav 20 (1984) 451-455
10. Goeders N.E., Smith J.E., and Lane J.D. Intracranial self-administration of the endocoid methionine-enkephalin. J Am Osteopath Assoc 84 (1984) 148-151
11. Gulat-Marnay C., Lafitte A., Arrang J.M., and Schwartz J.C. Modulation of histamine release in the rat brain by kappa-opioid receptors. J Neurochem 55 (1990) 47-53
12. Guttenberg N.D., Klop H., Minami M., Satoh M., and Voorn P. Co-localization of mu opioid receptor is greater with dynorphin than enkephalin in rat striatum. Neuroreport 7 (1996) 2119-2124
13. Han J.S. Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies. Trends Neurosci 26 (2003) 17-22
14. Han J.S., Trachtenberg A.I., and Lowinson J.H. In: Lowinson J.H., Ruis P., Millman R.B., and Langord J.G. (Eds). Substance abuse, a comprehensive textbook. 4th ed. (2005), Lippincott Williams & Wilkins, Philadelphia 743-762 [chapter 49]
15. Herkenham M., Edley S.M., and Stuart J. Cell clusters in the nucleus accumbens of the rat, and the mosaic relationship of opiate receptors, acetylcholinesterase and subcortical afferent terminations. Neuroscience 11 (1984) 561-593
16. Hiroi N., and White N.M. The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference. J Neurosci 11 (1991) 07-2116
17. Hirose N., Murakawa K., Takada K., Oi Y., Suzuki T., Nagase H., et al. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Neuroscience 135 (2005) 213-225
18. Jewett D.C., Grace M.K., Jones R.M., Billington C.J., Portoghese P.S., and Levin A.S. The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats. Brain Res 909 (2002) 75-80
19. Lewis M.E., Khachaturian H., and Watson S.J. Combined autoradiographic-immunocytochemical analysis of opioid receptors and opioid peptide neuronal systems in brain. Peptides 6 Suppl. 1 (1985) 37-47
20. Longoni R., Spina L., Mulas A., Carboni E., Garau L., Melchiorri P., et al. (D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens. J Neurosci 11 (1991) 1565-1576
21. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Aki H., et al. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350 (1994) 412-438
22. Mansour A., Khachaturian H., Lewis M.E., Akil H., and Watson S.J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7 (1987) 2445-2464
23. Margolis E.B., Hjelmstad G.O., Bonci A., and Fields H.L. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J Neurosci 23 (2003) 9981-9986
24. Markou A., Weiss F., Gold L.H., Caine S.B., Schulteis G., and Koob G.F. Animal models of drug craving. Psychopharmacology (Berl) 112 (1993) 163-182
25. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383 (1996) 819-823
26. Milekic M.H., Brown S.D., Castellini C., and Alberini C.M. Persistent disruption of an established morphine conditioned place preference. J Neurosci 26 (2006) 3010-3020
27. Minami M., and Satoh M. Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci Res 23 (1995) 121-145
28. Mucha R.F., and Herz A. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology (Berl) 86 (1985) 274-280
29. Narita M., Funada M., and Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 89 (2001) 1-15
30. Negus S.S., Burke T.F., Medzihradsky F., and Woods J.H. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine. J Pharmacol Exp Ther 267 (1993) 896-903
31. Neisewander J.L., Pierce R.C., and Bardo M.T. Naloxone enhances the expression of morphine-induced conditioned place preference. Psychopharmacology (Berl) 100 (1990) 201-205
32. Nieto M.M., Wilson J., Cupo A., Roques B.P., and Noble F. Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a microdialysis study. J Neurosci 22 (2002) 1034-1041
33. Okutsu H., Watanabe S., Takahashi I., Aono Y., Saigusa T., Koshikawa N., et al. Endomorphin-2 and endomorphin-1 promote the extracellular amount of accumbal dopamine via nonopioid and mu-opioid receptors, respectively. Neuropsychopharmacology 31 (2006) 375-383
34. Pentney R.J., and Gratton A. Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: an in vivo electrochemical study. Neuroscience 45 (1991) 95-102
35. Piepponen T.P., Kivastik T., Katajamaki J., Zharkovsky A., and Ahtee L. Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats. Pharmacol Biochem Behav 58 (1997) 275-279
36. Ren M.F., and Han J.S. Rat tail flick acupuncture analgesia model. Chin Med J 92 (1979) 576-582
37. Sante A.B., Nobre M.J., and Brandao M.L. Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter. Behav Pharmacol 11 (2000) 583-589
38. Shi X.D., Ren W., Wang G.B., Luo F., Han J.S., and Cui C.L. Brain opioid-receptors are involved in mediating peripheral electric stimulation-induced inhibition of morphine conditioned place preference in rats. Brain Res 981 (2003) 23-29
39. Shi X.D., Wang G.B., Ma Y.Y., Ren W., Luo F., Cui C.L., et al. Repeated peripheral electrical stimulations suppress both morphine-induced CPP and reinstatement of extinguished CPP in rats: accelerated expression of PPE and PPD mRNA in NAc implicated. Brain Res Mol Brain Res 130 (2004) 124-133
40. Shippenberg T.S., Bals-Kubik R., and Herz A. Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes. Brain Res 436 (1987) 234-239
41. Sohn J.H., Lee B.H., Park S.H., Ryu J.W., Kim B.O., and Park Y.G. Microinjection of opiates into the periaqueductal gray matter attenuates neuropathic pain symptoms in rats. Neuroreport 11 (2000) 1413-1416
42. Suarez-Roca H., and Maixner W. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices. J Pharmacol Exp Ther 264 (1993) 648-653
43. Suzuki T., Shiozaki Y., Masukawa Y., Misawa M., and Nagase H. The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference. Jpn J Pharmacol 58 (1992) 435-442
44. Tortella F.C., Echevarria E., Robles L., Mosberg H.I., and Holaday J.W. Anticonvulsant effects of mu (DAGO) and delta (DPDPE) enkephalins in rats. Peptides 9 (1988) 177-1181
45. van der K.D., Mucha R.F., O'Shaughnessy M., and Bucenieks P. Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference. Brain Res 243 (1982) 107-117
46. Wang B., Luo F., Xia Y.Q., and Han J.S. Peripheral electric stimulation inhibits morphine-induced place preference in rats. Neuroreport 11 (2000) 1017-1020
47. Wise R.A. Opiate reward: sites and substrates. Neurosci Biobehav Rev 13 (1989) 129-133
48. Yeadon M., and Kitchen I. Differences in the characteristics of opioid receptor binding in the rat and marmoset. J Pharm Pharmacol 40 (1988) 736-739